The diagnostic performance of lysine(K)-specific demethylase 6B (KDM6B) in non-small cell lung cancer

References

• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29.
   PubMed Web of Science ®Google Scholar
• Wang J, Yang B, Han L, et al. Demethylation of miR-9-3 and miR-193a genes suppresses proliferation and promotes apoptosis in non-small cell lung cancer cell lines. Cell Physiol Biochem. 2013;32:1707–1719.
   PubMedGoogle Scholar
• Li H, Zhang Y, Bai X, et al. TRIM31 is downregulated in non-small cell lung cancer and serves as a potential tumor suppressor. Tumor Biol. 2014;35:5747–5752.
   PubMedGoogle Scholar
• Sun M, Song J, Zhou Z, et al. Comparison of serum microRNA21 and tumor markers in diagnosis of early non-small cell lung cancer. Dis Markers. 2016;2016:3823121
   PubMed Web of Science ®Google Scholar
• Wink KC, Roelofs E, Solberg T, et al. Particle therapy for non-small cell lung tumors: where do we stand? A systematic review of the literature. Front Oncol. 2014;4:292.
   PubMedGoogle Scholar
• Reck M, Heigener DF, Mok T, et al. Management of non-small-cell lung cancer: recent developments. Lancet. 2013;382:709–719.
   PubMed Web of Science ®Google Scholar
• Arya SK, Bhansali S. Lung cancer and its early detection using biomarker-based biosensors. Chem Rev. 2011;111:6783–6809.
   PubMed Web of Science ®Google Scholar
• Cabrera-Alarcon JL, Carrillo-Vico A, Santotoribio JD, et al. CYFRA 21-1 as a tool for distant metastasis detection in lung cancer. Clin Lab. 2011;57:1011–1014.
   PubMed Web of Science ®Google Scholar
• Gridelli C, Rossi A, Maione P. 2010 Consensus on lung cancer, new clinical recommendations and current status of biomarker assessment–first-line therapy. Eur J Cancer. 2011;47: S248–S57.
   PubMed Web of Science ®Google Scholar
• Cho JY, Sung HJ. Proteomic approaches in lung cancer biomarker development. Expert Rev Proteomics. 2009;6:27–42.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang K, Xu J, et al. Prognostic significance of circulating tumor cells in non-small-cell lung cancer patients: a meta-analysis. PloS One. 2013;8:e78070.
   PubMed Web of Science ®Google Scholar
• Hoffmann I, Roatsch M, Schmitt ML, et al. The role of histone demethylases in cancer therapy. Mol Oncol. 2012;6:683–703.
   PubMed Web of Science ®Google Scholar
• Yamane K, Tateishi K, Klose RJ, et al. PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. Mol Cell. 2007;25:801–812.
   PubMed Web of Science ®Google Scholar
• Kim JH, Sharma A, Dhar SS, et al. UTX and MLL4 coordinately regulate transcriptional programs for cell proliferation and invasiveness in breast cancer cells. Cancer Res. 2014;74:1705–1717.
   PubMed Web of Science ®Google Scholar
• Teng YC, Lee CF, Li YS, et al. Histone demethylase RBP2 promotes lung tumorigenesis and cancer metastasis. Cancer Res. 2013;73:4711–4721.
   PubMed Web of Science ®Google Scholar
• Pires-Luis AS, Vieira-Coimbra M, Vieira FQ, et al. Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication. Epigenetics. 2015;10:1033–1043.
   PubMed Web of Science ®Google Scholar
• Tokunaga R, Sakamoto Y, Nakagawa S, et al. The prognostic significance of histone lysine demethylase JMJD3/KDM6B in colorectal cancer. Ann Surg Oncol. 2016;23:678–685.
   PubMed Web of Science ®Google Scholar
• Ene CI, Edwards L, Riddick G, et al. Histone demethylase Jumonji D3 (JMJD3) as a tumor suppressor by regulating p53 protein nuclear stabilization. PloS One. 2012;7:e51407.
   PubMed Web of Science ®Google Scholar
• Ma J, Wang N, Zhang Y, et al. KDM6B elicits cell apoptosis by promoting nuclear translocation of FOXO1 in non-small cell lung cancer. Cell Physiol Biochem. 2015;37:201–213.
   PubMed Web of Science ®Google Scholar
• Taverna S, Giallombardo M, Gil-Bazo I, et al. Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice. Oncotarget. 2016;7(19):28748–28760.
   PubMedGoogle Scholar
• Campbell MJ, Turner BM. Altered histone modifications in cancer. Adv Exp Med Biol. 2013;754:81–107.
   PubMed Web of Science ®Google Scholar
• Klose RJ, Kallin EM, Zhang Y. JmjC-domain-containing proteins and histone demethylation. Nat Rev Genet. 2006;7:715–727.
   PubMed Web of Science ®Google Scholar
• Varier RA, Timmers HT. Histone lysine methylation and demethylation pathways in cancer. Biochim Biophys Acta. 2011;1815:75–89.
   PubMed Web of Science ®Google Scholar
• Ke XS, Qu Y, Rostad K, et al. Genome-wide profiling of histone h3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis. PloS One. 2009;4:e4687.
   PubMed Web of Science ®Google Scholar
• Rada-Iglesias A, Enroth S, Andersson R, et al. Histone H3 lysine 27 trimethylation in adult differentiated colon associated to cancer DNA hypermethylation. Epigenetics. 2009;4:107–113.
   PubMed Web of Science ®Google Scholar
• Tian C, Deng H, Tang X, et al. Effect of Jumonji domain-containing protein-3 on the proliferation and migration of lung cancer cell line. Sheng wu yi Xue Gong Cheng Xue za Zhi  =  J Biomed Eng  =  Shengwu Yixue Gongchengxue Zazhi. 2012;29:514–518.
   PubMedGoogle Scholar
• Holdenrieder S, Nagel D, Stieber P. Estimation of prognosis by circulating biomarkers in patients with non-small cell lung cancer. CBM. 2010;6:179–190.
   Web of Science ®Google Scholar
• Yamamoto K, Tateishi K, Kudo Y, et al. Loss of histone demethylase KDM6B enhances aggressiveness of pancreatic cancer through down-regulation of C/EBPalpha. Carcinogenesis. 2014;35:2404–2414.
   PubMed Web of Science ®Google Scholar
• Pereira F, Barbachano A, Silva J, et al. KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells. Human Mol Genet. 2011;20:4655–4665.
   PubMed Web of Science ®Google Scholar
• Anderton JA, Bose S, Vockerodt M, et al. The H3K27me3 demethylase, KDM6B, is induced by Epstein–Barr virus and over-expressed in Hodgkin's lymphoma. Oncogene. 2011;30:2037–2043.
   PubMed Web of Science ®Google Scholar
• Li Q, Hou L, Ding G, et al. KDM6B induces epithelial-mesenchymal transition and enhances clear cell renal cell carcinoma metastasis through the activation of SLUG. Int J Clin Exp Pathol. 2015;8:6334–6344.
   PubMed Web of Science ®Google Scholar